{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:24:15Z","timestamp":1790745855405,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ijcard.2024.132228","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T06:40:39Z","timestamp":1717483239000},"page":"132228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients"],"prefix":"10.1016","volume":"410","author":[{"given":"Tamer","family":"Abu Arab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Sedhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"El Etriby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.132228_bb0005","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.ihj.2016.12.012","article-title":"Predictors of no-reflow during primary angioplasty for acute myocardial infarction, from medical college hospital, Trivandrum","volume":"69","author":"Sabin","year":"2017","journal-title":"Indian Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132228_bb0010","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/01.CIR.89.6.2514","article-title":"Incidence and treatment of\u2019no-reflow\u2019after percutaneous coronary intervention","volume":"89","author":"Piana","year":"1994","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2024.132228_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132228_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mhj.2003.36","article-title":"No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention","volume":"145","author":"Resnic","year":"2003","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132228_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.93.2.223","article-title":"Clinical implications of the \u2018no reflow\u2019phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction","volume":"93","author":"Ito","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132228_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/157016106776359835","article-title":"Pharmacological management of no reflow during percutaneous coronary intervention","volume":"4","author":"Porto","year":"2006","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132228_bb0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ccd.21334","article-title":"High dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo-controlled pilot study","volume":"71","author":"Stoel","year":"2008","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132228_bb0040","first-page":"121","article-title":"The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention","volume":"13","author":"Ramjane","year":"2008","journal-title":"Exp. Clin. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132228_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12872-015-0004-6","article-title":"Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study","volume":"15","author":"Aksu","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"issue":"9","key":"10.1016\/j.ijcard.2024.132228_bb0050","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jcin.2010.05.017","article-title":"Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes","volume":"3","author":"Prati","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132228_bb0055","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/joic.12318","article-title":"Efficacy and safety of local intracoronary drug delivery in treatment of no-reflow phenomenon: a pilot study","volume":"29","author":"Abu Arab","year":"2016","journal-title":"J. Interv. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132228_bb0060","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4070\/kcj.2013.43.11.739","article-title":"Usefulness of intracoronary epinephrine in severe hypotension during percutaneous coronary interventions","volume":"43","author":"Choi","year":"2013","journal-title":"Korean Circ. J."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132228_bb0065","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jcin.2015.04.028","article-title":"Intracoronary Adenosine: Dose\u2013Response Relationship With Hyperemia","volume":"8","author":"Adjedj","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132228_bb0070","first-page":"E23","article-title":"Use of monorail PTCA balloon catheter for local drug delivery","volume":"19","author":"Trehan","year":"2007","journal-title":"J. Invasiv. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcard.2024.132228_bb0075","doi-asserted-by":"crossref","first-page":"e10850","DOI":"10.1097\/MD.0000000000010850","article-title":"Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention","volume":"97","author":"Hu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132228_bb0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.ijcard.2024.132228_bb0085","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1161\/01.CIR.0000065221.06430.ED","article-title":"Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade","volume":"107","author":"Henriques","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132228_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge","volume":"76","author":"Chesebro","year":"1987","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ijcard.2024.132228_bb0095","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0002-9149(99)80410-X","article-title":"Features and outcome of no-reflow after percutaneous coronary intervention","volume":"75","author":"Abbo","year":"1995","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132228_bb0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/14779072.5.4.715","article-title":"Percutaneous coronary intervention and the no-reflow phenomenon","volume":"5","author":"Van Gaal","year":"2007","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132228_bb0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pharmthera.2011.05.010","article-title":"Management of the no-reflow phenomenon","volume":"132","author":"Butler","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132228_bb0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcin.2016.11.059","article-title":"Management of no-reflow phenomenon in the catheterization laboratory","volume":"10","author":"Rezkalla","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132228_bb0115","first-page":"141","article-title":"Distal administration of very high doses of intracoronary adenosine for the treatment of resistant no-reflow","volume":"13","author":"Movahed","year":"2008","journal-title":"Exp. Clin. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132228_bb0120","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ccd.10375","article-title":"Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction","volume":"57","author":"Werner","year":"2002","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132228_bb0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ahj.2012.06.015","article-title":"REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER)","volume":"164","author":"Huang","year":"2012","journal-title":"Am. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2024.132228_bb0135","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/hrt.2005.075077","article-title":"Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes","volume":"92","author":"Vijayalakshmi","year":"2006","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ijcard.2024.132228_bb0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ccd.10303","article-title":"Resolution of refractory no-reflow with intracoronary epinephrine","volume":"57","author":"Skelding","year":"2002","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132228_bb0145","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ccd.29113","article-title":"Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: the RESTORE observational study","volume":"97","author":"Navarese","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324008507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324008507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T22:38:17Z","timestamp":1719614297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324008507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"alternative-id":["S0167527324008507"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132228","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"132228"}}